share_log

康哲藥業:截至二零二四年三月三十一日止月份之股份發行人的證券變動月報表

CMS: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024

香港交易所 ·  Apr 2 05:33
Summary by Moomoo AI
康哲藥業控股有限公司於2024年3月31日提交了最新的證券變動月報表給香港交易及結算所有限公司。報告顯示,截至2024年3月底,公司的法定/註冊股本結存維持在20,000,000,000股,每股面值0.005美元,總額為100,000,000美元,與上月相比無變動。此外,報告中未提及有關股份期權、權證、可換股票據或其他協議的變動,並確認公司已遵守所有相關法律規定,所有交易已完成且款項已繳付。公司秘書吳三燕於2024年4月2日呈交了該報表。
康哲藥業控股有限公司於2024年3月31日提交了最新的證券變動月報表給香港交易及結算所有限公司。報告顯示,截至2024年3月底,公司的法定/註冊股本結存維持在20,000,000,000股,每股面值0.005美元,總額為100,000,000美元,與上月相比無變動。此外,報告中未提及有關股份期權、權證、可換股票據或其他協議的變動,並確認公司已遵守所有相關法律規定,所有交易已完成且款項已繳付。公司秘書吳三燕於2024年4月2日呈交了該報表。
CONGE PHARMACEUTICAL HOLDINGS LIMITED SUBMITTED ITS LATEST MONTHLY STATEMENT OF CHANGES IN SECURITIES TO HONG KONG TRADING AND SETTLEMENT LIMITED ON 31 MARCH 2024. The report shows that as of the end of March 2024, the company's regulated/registered share capital remained at 20,000,000,000 shares with a face value of $0.005 per share for a total of $100,000,000, unchanged from the previous month. In addition, the report does not mention changes in stock options, warrants, convertible notes or other agreements and confirms that the Company has complied with all relevant legal requirements and that all transactions have been completed and payments have been paid. Company Secretary Wu Sanyan submitted the report on April 2, 2024.
CONGE PHARMACEUTICAL HOLDINGS LIMITED SUBMITTED ITS LATEST MONTHLY STATEMENT OF CHANGES IN SECURITIES TO HONG KONG TRADING AND SETTLEMENT LIMITED ON 31 MARCH 2024. The report shows that as of the end of March 2024, the company's regulated/registered share capital remained at 20,000,000,000 shares with a face value of $0.005 per share for a total of $100,000,000, unchanged from the previous month. In addition, the report does not mention changes in stock options, warrants, convertible notes or other agreements and confirms that the Company has complied with all relevant legal requirements and that all transactions have been completed and payments have been paid. Company Secretary Wu Sanyan submitted the report on April 2, 2024.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more